Acuren Total Depreciation and Amortization - Cash Flow 2023-2025 | TIC

Acuren total depreciation and amortization - cash flow from 2023 to 2025. Total depreciation and amortization - cash flow can be defined as the total amount of depreciation and amortization listed on the Cash Flows Statement

Acuren Total Depreciation and Amortization - Cash Flow 2023-2025 | TIC

Acuren total depreciation and amortization - cash flow from 2023 to 2025. Total depreciation and amortization - cash flow can be defined as the total amount of depreciation and amortization listed on the Cash Flows Statement
Related Stocks
Company NameMarket
Cap
Abbott Laboratories (ABT)$232.4B
Boston Scientific (BSX)$153.7B
Stryker (SYK)$150.7B
EssilorLuxottica (ESLOY)$135.2B
Medtronic (MDT)$114.7B
Lonza Group Ag (LZAGY)$51.4B
Haleon (HLN)$45.4B
ResMed (RMD)$37.8B
Agilent Technologies (A)$35.3B
GE HealthCare Technologies (GEHC)$35B
Terumo (TRUMY)$24.7B
Koninklijke Philips (PHG)$23.7B
Insulet (PODD)$20.9B
Zimmer Biomet Holdings (ZBH)$18.8B
Baxter (BAX)$15.2B
Smith & Nephew SNATS (SNN)$13.6B
Demant (WILYY)$9B
Sunny Optical Technology (SNPTF)$8.6B
Bio-Rad Laboratories (BIO)$7.1B
Lantheus Holdings (LNTH)$5.8B
Prestige Consumer Healthcare (PBH)$3.8B
Haemonetics (HAE)$3.8B
Perrigo (PRGO)$3.7B
Envista Holdings (NVST)$3.5B
Shandong Weigao Medical Polymer (SHWGF)$3.5B
ICU Medical (ICUI)$3.4B
QuidelOrtho (QDEL)$2.1B
LeMaitre Vascular (LMAT)$1.9B
AtriCure (ATRC)$1.6B
Green Thumb Industries (GTBIF)$1.4B